Arcturus Therapeutics Ltd. Retained Earnings
Arcturus Therapeutics Ltd. had Retained Earnings of -$52.56 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-05-13
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$52.56M.
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$44.87M.
- 2018-09-30: Retained Earnings (Accumulated Deficit) -$43.86M.
- 2018-06-30: Retained Earnings (Accumulated Deficit) -$39.61M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2019-03-31 | -$52.56M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | -$44.87M 10-Q · filed 2019-05-13 | |
| 2018-09-30 | -$43.86M 6-K · filed 2018-11-07 | |
| 2018-06-30 | -$39.61M 6-K · filed 2018-09-28 | |
| 2017-12-31 | -$23.09M 10-K · filed 2019-03-18 | |
| 2016-12-31 | -$12.19M 20-F · filed 2018-05-14 | -$95.62M 20-F · filed 2017-04-28 |
| 2015-12-31 | -$71.02M 20-F · filed 2017-04-28 | |
| 2014-12-31 | -$51.57M 20-F · filed 2016-03-04 |